REGN vs THC · P/E 14, rev $14.34B vs P/E 9.3, rev $20.66B
Regeneron Pharmaceuticals Inc (REGN) versus Tenet Healthcare Corporation (THC) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Tenet Healthcare Corporation (THC) is a medical care facilities company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported THC revenue for 2024-12-31 was $20.66B. Net income was $4.06B. Revenue was up 0.6% from 2023-12-31 to 2024-12-31. THC currently screens at market cap $15.38B and trailing P/E 9.3.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. THC currently screens at market cap $15.38B and trailing P/E 9.3.
Not investment advice. Open the REGN and THC stock pages for the full models.
Not investment advice.